DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 01 · Volume 41 · 1979 DOI: 10.1055/s-009-45108

Dedication

3
SHERRY, Sol: A Tribute to Kenneth M. Brinkhous, M. D.
27
Morris, G.K.: Preoperative Prediction of Postoperative Deep Vein Thrombosis
33
Browse, N. L.: Comments by the Designated Discussant
37
General Discussion
43
Gent, M.; Hirsh, J.: Definition of High Risk/High Response Population for Stroke in Patients with Transient Ischemic Attacks
59
General Discussion
63
Prentice, C. R. M.: Which Patients with Coronary Artery Disease are Most Prone to Develop a Coronary Artery Event (Presumably Thrombosis)?
73
Oliver, M. F.: Design of Clinical Trials in Thrombosis
77
General Discussion
83
Tudor Davies, W.: South Wales Multicenter Trial of Prophylactic Dextran 70 after Surgery: a Clinically Oriented Randomized Double-blind Trial
91
Vessey, M. P.: Comments of an Epidemiologist
95
Salzman, Edwin W.: The Surgeon’s Comments I
97
Kakkar, V. V.: The Surgeon’s Comments 11
99
Saldeen, Tom: Invited Discussant
105
Kakkar, V. V.: The Logistic Problems Encountered in the Multicenter Trial of Low-Dose Heparin Prophylaxis
121
Browse, N. L.: The Prophylaxis of Deep Vein Thrombosis
123
Gent, M.; Sackett, D. L.: The Qualification and Disqualification of Patients and Events in Long-Term Cardiovascular Clinical Trials
135
Fields, W.S.; Lemak, N.A.; Frankowski, R.F.; Hardy, R.J.: Controlled Trial of Aspirin in Cerebral Ischemia (AITIA Study)
143
Armitage, P.: The Statistician’s Comments
147
Ross Russell, R. W.: The Neurologist’s Comments
151
Whisnant, Jack P.: Invited Discussant
153
General Discussion
163
Gent, M.: The Canadian Cooperative Study of Platelet Suppressant Therapy in Threatened Stroke
171
Armitage, P.: The Statistician’s Comments
177
Ross Russell, R.W.: The Neurologist’s Comments
181
Whisnant, J.P.: Invited Discussant
187
General Discussion
197
Sherry, Sol: The Anturane Reinfarction Trial
203
Meade, T. W.: The Epidemiologist’s Comments
209
Oliver, M.F.: The Cardiologist’s Comments
213
Klimt, C.R.: Invited Discussant
217
Boissel, J. P.: Invited discussant
221
General Discussion
225
Breddin, K.; Loew, D.; Lechner, K.; Überla, K.; Walter, E.: Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo
237
Überla, K.: Statistical Evidence of the German-Austrian Secondary Prevention Trial
243
Meade, T.W.: The Epidemiologist’s Comments
247
Oliver, M.F.: The Cardiologist’s Comments
249
Loeliger, E. A.: Invited Discussant of the German-Austrian Study Group Report
255
Barrillon, A.; Kusmierek, J.; Gerbaux, A.: Occlusive Coronary Thrombosis and Oral Anticoagulants
265
General Discussion of the German-Austrian Study Group Report
267
Brinkhous, K.M.: Armand J. Quick, Ph.D., M.D. 1894-1978
271
Brinkhous, K.M.: Benjamin Alexander, M.D. 1909-1978